These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 8589717)

  • 1. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I.
    Overturf K; Al-Dhalimy M; Tanguay R; Brantly M; Ou CN; Finegold M; Grompe M
    Nat Genet; 1996 Mar; 12(3):266-73. PubMed ID: 8589717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
    Grompe M; Lindstedt S; al-Dhalimy M; Kennaway NG; Papaconstantinou J; Torres-Ramos CA; Ou CN; Finegold M
    Nat Genet; 1995 Aug; 10(4):453-60. PubMed ID: 7545495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo hepatic gene therapy of a mouse model of Hereditary Tyrosinemia Type I.
    Overturf K; Al-Dhalimy M; Manning K; Ou CN; Finegold M; Grompe M
    Hum Gene Ther; 1998 Feb; 9(3):295-304. PubMed ID: 9508047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity.
    Jacobs SM; van Beurden DH; Klomp LW; Berger R; van den Berg IE
    Pediatr Res; 2006 Mar; 59(3):365-70. PubMed ID: 16492973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model.
    Orejuela D; Jorquera R; Bergeron A; Finegold MJ; Tanguay RM
    J Hepatol; 2008 Feb; 48(2):308-17. PubMed ID: 18093685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
    Eggenhofer E; Doenecke A; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
    J Gastroenterol Hepatol; 2010 May; 25(5):1002-8. PubMed ID: 20546455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.
    Grompe M; Overturf K; al-Dhalimy M; Finegold M
    J Inherit Metab Dis; 1998 Aug; 21(5):518-31. PubMed ID: 9728332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death.
    Vogel A; van Den Berg IE; Al-Dhalimy M; Groopman J; Ou CN; Ryabinina O; Iordanov MS; Finegold M; Grompe M
    Hepatology; 2004 Feb; 39(2):433-43. PubMed ID: 14767996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Round two for liver gene therapy.
    Wilson JM
    Nat Genet; 1996 Mar; 12(3):232-3. PubMed ID: 8589710
    [No Abstract]   [Full Text] [Related]  

  • 10. Tyrosine and its catabolites: from disease to cancer.
    Tanguay RM; Jorquera R; Poudrier J; St-Louis M
    Acta Biochim Pol; 1996; 43(1):209-16. PubMed ID: 8790725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of fumarylacetoacetate hydrolase deficiency (type I tyrosinemia) in cultured human fibroblasts by retroviral-mediated gene transfer.
    Phaneuf D; Hadchouel M; Tanguay RM; Bréchot C; Ferry N
    Biochem Biophys Res Commun; 1995 Mar; 208(3):957-63. PubMed ID: 7702626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanted bone marrow regenerates liver by cell fusion.
    Vassilopoulos G; Wang PR; Russell DW
    Nature; 2003 Apr; 422(6934):901-4. PubMed ID: 12665833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dichloroacetate treatment in a murine model of hereditary tyrosinemia type 1.
    Langlois C; Jorquera R; Finegold M; Shroads AL; Stacpoole PW; Tanguay RM
    Biochem Pharmacol; 2006 May; 71(11):1648-61. PubMed ID: 16581029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of murine histidinaemia and its potential for genetic manipulation.
    Mellor N; Themis M; Selden C; Jones M; Hodgson HJ
    Liver Int; 2004 Aug; 24(4):354-60. PubMed ID: 15287859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M; Tanguay RM
    Hum Mutat; 1997; 9(4):291-9. PubMed ID: 9101289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
    Hickey RD; Mao SA; Glorioso J; Elgilani F; Amiot B; Chen H; Rinaldo P; Marler R; Jiang H; DeGrado TR; Suksanpaisan L; O'Connor MK; Freeman BL; Ibrahim SH; Peng KW; Harding CO; Ho CS; Grompe M; Ikeda Y; Lillegard JB; Russell SJ; Nyberg SL
    Sci Transl Med; 2016 Jul; 8(349):349ra99. PubMed ID: 27464750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation restores liver function in Fah-knockout mice.
    Eggenhofer E; Popp FC; Renner P; Slowik P; Neuwinger A; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2008 Nov; 36(11):1507-13. PubMed ID: 18715687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
    Poudrier J; St-Louis M; Lettre F; Gibson K; Prévost C; Larochelle J; Tanguay RM
    Prenat Diagn; 1996 Jan; 16(1):59-64. PubMed ID: 8821854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
    Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
    Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo selection of hepatocytes transduced with adeno-associated viral vectors.
    Chen SJ; Tazelaar J; Moscioni AD; Wilson JM
    Mol Ther; 2000 May; 1(5 Pt 1):414-22. PubMed ID: 10933962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.